Word (http://tools.niehs.nih.gov/portfolio/sc/detail_doc.cfm?appl_id=7487855&ext=.doc)
|
Excel (http://tools.niehs.nih.gov/portfolio/sc/detail_xls.cfm?appl_id=7487855&ext=.xls)
|
PDF (http://tools.niehs.nih.gov/portfolio/sc/detail_doc.cfm?appl_id=7487855&pdf=1&ext=.pdf)
The Role of Ikaros in Regulatory T Cells That Protect Against Allergic Asthma
Principal Investigator
Umetsu, Sarah
Institute Receiving Award
Northwestern University
Location
Chicago, IL
Grant Number
F30ES015971
Funding Organization
National Institute of Environmental Health Sciences
Award Funding Period
01 Sep 2007to31 Aug 2012
DESCRIPTION (provided by applicant): Asthma is a complex disorder influenced by the interaction of genetic and environmental factors such as exposure to allergens, infections, and air pollution. Excessive Th2 biased immune responses to environmental antigens are thought to cause pulmonary inflammation, airway eosinophilia, mucus hypersecretion and airway hyperreactivity (AHR), cardinal features of asthma. Recent studies have shown that regulatory T (Treg) cells play an important role in controlling the pathogenic immune responses seen in asthma, and the development of Treg cells is thought to protect against asthma. Although therapies that induce Treg cells would provide a cure for patients with asthma, little is known about how to induce Treg cells, how Treg cells develop, or how they suppress allergic immune responses. In order to improve the treatments for asthma and to develop strategies that might routinely induce Treg cells that suppress inflammation in asthma, further understanding of the mechanisms controlling the development and function of these cells is required. Preliminary experiments in our laboratory (see preliminary results section) have shown that in the absence of Ikaros, a transcription factor expressed in early T-cell progenitors as well as in mature T cells, the development of CD25+Foxp3+ Treg cells is significantly reduced. In addition, the production of IL-10, a critical cytokine normally secreted by both Treg cells and dendritic cells that induce Treg cells, is greatly reduced in Ikaros-/- T cells. This suggests that Ikaros critically regulates the development of Treg cells as well as the production of IL-10. The goal, therefore, of this proposal, is to study the role of Ikaros in the development of Treg cells that protect against allergic asthma. In Specific Aim 1, we will examine the molecular mechanisms of Ikaros as a transcription factor that controls 1110 gene expression. In Specific Aim 2, we will use in vitro proliferation assays to compare purified Ikaros-/- and wild type Treg cells in order to investigate if Ikaros regulates Treg cell function. Finally, in Specific Aim 3, we will examine the function of Ikaros in an in vivo mouse model of asthma, to demonstrate how lack of Ikaros in Treg cells impacts airway inflammation and AHR induced by common environmental antigens. Asthma is a complex disease that occurs due to a combination of environmental and genetic factors. The breakdown in normal regulation of the immune system is of major significance in the development of this disease. Regulatory T cells play an important role in controlling the immune response and thus, it is of therapeutic importance to further understand the mechanisms controlling regulatory T cell function.
Crisp Terms/Key Words:
Science Code(s)/Area of Science(s)
Primary: 87 - Training Secondary: 69 - Respiratory
|